Testing new vaccines for coronavirus
PHASE 1 AND PHASE 2 CLINICAL TRIALS FOR NEXT-GENERATION CORONAVIRUS VACCINES
This study is looking for people to help test new coronavirus vaccines to see how safe and effective they are, with the hope of finding better ways to protect everyone from the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-10887806 on NIH RePORTER |
What this research studies
This research focuses on conducting early-stage clinical trials to evaluate next-generation vaccines designed to combat coronavirus. Patients may participate in Phase 1 and Phase 2 trials, where their responses to the vaccine candidates will be monitored to gather important safety and efficacy data. The trials aim to identify the most promising vaccine candidates for further development, which could ultimately lead to more effective protection against coronavirus. Participants will be closely observed and may receive new vaccine formulations that are being tested for their potential benefits.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals who are at risk of coronavirus infection or those who are interested in contributing to vaccine development.
Not a fit: Patients who are not at risk for coronavirus or those who have already received a vaccine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines against coronavirus, enhancing public health and safety.
How similar studies have performed: Other research has shown success with similar approaches in vaccine development, indicating a promising path forward.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Datta, Kiran — Leidos Biomedical Research, INC.
- Study coordinator: Datta, Kiran
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.